Canopy Growth to Report Second Quarter Fiscal 2023 Financial Results on November 9, 2022

<br /> Canopy Growth to Report Second Quarter Fiscal 2023 Financial Results on November 9, 2022<br />

Canada NewsWire

SMITHS FALLS, ON

,

Oct. 27, 2022

/CNW/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the second quarter fiscal year 2023 ended September 30, 2022 before financial markets open on

November 9, 2022

.

Following the release of its second quarter fiscal year 2023 financial results, Canopy Growth will host an audio webcast with

David Klein

, CEO and

Judy Hong

, CFO on

November 9, 2022

, at

10:00 AM Eastern Time

.

Shareholders can submit questions starting on November 2, 2022, at

10:00 AM ET

by visiting:

https://app.saytechnologies.com/canopy-growth-corporation-2023-q2

.

The platform will close on

November 8, 2022

, at

10:00 AM ET

.

Webcast Information

A live audio webcast will be available at:

https://app.webinar.net/nwPeJ3EBZG8

Replay Information

A replay will be accessible by webcast until

11:59 PM ET

on

February 8, 2023

at:

https://app.webinar.net/nwPeJ3EBZG8

About Canopy Growth Corporation

Canopy Growth (TSX:

WEED)

(NASDAQ: CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both

Canada

and

Germany

. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including

Canada

,

the United States

, and

Europe

through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to

the United States

through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit

www.canopygrowth.com

.

Notice Regarding Forward Looking Statements

This press release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward-looking statements”), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as “intend,” “goal,” “strategy,” “estimate,” “expect,” “project,” “projections,” “forecasts,” “plans,” “seeks,” “anticipates,” “potential,” “proposed,” “will,” “should,” “could,” “would,” “may,” “likely,” “designed to,” “foreseeable future,” “believe,” “scheduled” and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward‐looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward‐looking statements and the forward‐looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation (“Canopy”) can be found under the section entitled “Risk Factors” in Canopy’s Annual Report on Form 10-K for the year ended

March 31, 2022

, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at

www.sec.gov/edgar

and

www.sedar.com

, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward‐looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward‐ looking statement. Readers are cautioned not to put undue reliance on any forward‐looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.